Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
discovered a new factor in the pathology of Parkinson's disease, which in the future may serve as a target for developing new ...
GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...
The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...
News Medical on MSN1d
New biomarker could help predict Parkinson’s disease progressionA team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
offering a new therapeutic ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...
People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study examined the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback